Product Description

🔹 Product Overview
Pamorelin 11.25 mg Injection is a prescription hormonal therapy medicine used in the treatment of hormone-dependent conditions.
Contains Triptorelin 11.25 mg, a gonadotropin-releasing hormone (GnRH) agonist that helps regulate sex hormone production.
It is formulated as a long-acting depot injection, providing therapeutic effects for approximately 12 weeks.

🔹 Key Uses
Treatment of advanced hormone-dependent prostate cancer
Management of locally advanced prostate cancer
Treatment of central precocious puberty (early puberty)
Used in selected cases of endometriosis, uterine fibroids, and assisted reproductive therapies under specialist supervision.

🔹 Composition
Active ingredient: Triptorelin 11.25 mg
Belongs to the GnRH agonist class
Available as a prolonged-release injectable suspension

🔹 How It Works
Initially stimulates the release of reproductive hormones.
Continued treatment suppresses the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Reduces testosterone levels in men, helping slow the growth of hormone-sensitive prostate cancer cells.
In children with precocious puberty, it delays premature sexual development.

🔹 Key Benefits
Effective prostate cancer hormonal therapy
Long-acting formulation requiring administration every 3 months
Helps control symptoms associated with hormone-dependent cancers
Supports management of central precocious puberty
Reduces the need for frequent injections

🔹 Dosage and Administration
Administered only by a qualified healthcare professional
Usually given as an intramuscular injection every 12 weeks
Dosage and duration depend on the medical condition being treated
Follow scheduled appointments for optimal therapeutic outcomes

🔹 Possible Side Effects
Hot flushes
Excessive sweating
Injection site reactions
Headache
Fatigue or weakness
Back pain
Reduced libido
Mood changes

🔹 Precautions
Use only under specialist medical supervision.
Inform your doctor about any history of heart disease, diabetes, osteoporosis, or depression.
Not recommended during pregnancy or breastfeeding.
Regular monitoring of hormone levels and treatment response may be required.
Seek immediate medical advice if severe neurological symptoms occur.